On March 16, 2010 FDA ordered Glenmark Generics and Konec to cease manufacturing and distribution of nitroglycerin tablets.  These actions are part of the FDA program to remove unapproved products from the market.  In this case, Pfizer makes the approved product, so these removed products can be thought of as unauthorized generics.